1. Home
  2. BCYC vs GES Comparison

BCYC vs GES Comparison

Compare BCYC & GES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • GES
  • Stock Information
  • Founded
  • BCYC 2009
  • GES 1981
  • Country
  • BCYC United Kingdom
  • GES Switzerland
  • Employees
  • BCYC N/A
  • GES N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • GES Apparel
  • Sector
  • BCYC Health Care
  • GES Consumer Discretionary
  • Exchange
  • BCYC Nasdaq
  • GES Nasdaq
  • Market Cap
  • BCYC 566.5M
  • GES 547.7M
  • IPO Year
  • BCYC 2019
  • GES 1996
  • Fundamental
  • Price
  • BCYC $7.03
  • GES $12.46
  • Analyst Decision
  • BCYC Buy
  • GES Buy
  • Analyst Count
  • BCYC 10
  • GES 4
  • Target Price
  • BCYC $25.00
  • GES $17.75
  • AVG Volume (30 Days)
  • BCYC 272.6K
  • GES 900.8K
  • Earning Date
  • BCYC 08-05-2025
  • GES 06-05-2025
  • Dividend Yield
  • BCYC N/A
  • GES 9.61%
  • EPS Growth
  • BCYC N/A
  • GES N/A
  • EPS
  • BCYC N/A
  • GES 0.10
  • Revenue
  • BCYC $25,722,000.00
  • GES $3,051,131,000.00
  • Revenue This Year
  • BCYC $7.35
  • GES $7.34
  • Revenue Next Year
  • BCYC N/A
  • GES $3.20
  • P/E Ratio
  • BCYC N/A
  • GES $129.19
  • Revenue Growth
  • BCYC N/A
  • GES 9.02
  • 52 Week Low
  • BCYC $6.10
  • GES $8.48
  • 52 Week High
  • BCYC $28.67
  • GES $24.64
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 32.48
  • GES 57.92
  • Support Level
  • BCYC $7.03
  • GES $11.80
  • Resistance Level
  • BCYC $7.59
  • GES $12.16
  • Average True Range (ATR)
  • BCYC 0.43
  • GES 0.42
  • MACD
  • BCYC -0.11
  • GES 0.02
  • Stochastic Oscillator
  • BCYC 0.81
  • GES 71.53

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About GES Guess? Inc.

Guess? Inc designs, markets distributes, and licenses contemporary apparel and accessories that reflect European fashion sensibilities and American Lifestyle under brands including Guess, Marciano, and G by Guess. The company has five reportable segments: Americas Retail, Americas Wholesale, Europe, Asia, and licensing. Geographically, the company derives maximum revenue from the United States.

Share on Social Networks: